GST : 06AAGCN3218E1ZT
5.0/5
Our Product / Services
Leading Manufacturer, Supplier & Retailer of Cefuroxime Axetil Tablets, Clindamycin Capsule, Ceftriaxone 500 Mg Injection, ofloxacin & ornidazole tablets and LINEZOLID TABLETS.
Antibiotic
Traxium 500 Injection
**Ceftriaxone 500 mg Injection** is a broad-spectrum antibiotic used to treat a wide range of bacterial infections. It belongs to the class of third-generation cephalosporins and works by inhibiting the synthesis of bacterial cell walls, leading to the destruction of bacteria.
Ceftriaxone is commonly prescribed for infections such as respiratory tract infections, skin infections, urinary tract infections, gonorrhea, meningitis, and sepsis. It is also effective against certain strains of Gram-positive and Gram-negative bacteria.
The injection is usually administered intravenously (IV) or intramuscularly (IM) by a healthcare professional. It is often preferred for serious infections or when oral antibiotics are not suitable. The 500 mg dose may be adjusted depending on the severity of the infection and the patient's medical condition.
**Precautions**:
- Patients with a known allergy to cephalosporins or penicillin should inform their healthcare provider before receiving this medication.
- It is important to complete the full course of treatment, even if symptoms improve early, to avoid bacterial resistance.
- Common side effects may include pain at the injection site, nausea, diarrhea, or allergic reactions.
As with all antibiotics, proper medical supervision is essential when using Ceftriaxone to ensure the effectiveness of the treatment and reduce the risk of antibiotic resistance.
Traxium S 1.5 Injection
**Ceftriaxone 1000 mg + Sulbactam 500 mg Injection** is a combination antibiotic used to treat a wide range of bacterial infections. It contains two active ingredients:
- **Ceftriaxone**, a third-generation cephalosporin antibiotic, works by inhibiting bacterial cell wall synthesis, effectively killing and preventing the growth of bacteria.
- **Sulbactam**, a beta-lactamase inhibitor, helps protect ceftriaxone from being broken down by beta-lactamase enzymes produced by some resistant bacteria, enhancing the efficacy of the antibiotic.
This combination is typically used to treat severe infections, such as those affecting the respiratory tract, urinary tract, skin, soft tissues, bones, joints, and the abdomen. It is administered via intramuscular or intravenous injection under medical supervision.
**Indications**:
- Bacterial infections resistant to standard treatments
- Complicated intra-abdominal infections
- Skin and soft tissue infections
- Pneumonia, urinary tract infections, septicemia, and more
**Dosage and Administration**:
The dose is determined by a healthcare professional based on the type and severity of the infection, as well as patient-specific factors such as age, weight, and kidney function.
**Precautions**:
- Avoid in patients with known hypersensitivity to ceftriaxone, sulbactam, or other beta-lactam antibiotics.
- Use with caution in individuals with liver or kidney dysfunction.
- Not recommended for use in neonates with jaundice due to risk of bilirubin displacement.
**Side Effects**:
Common side effects include nausea, diarrhea, injection site reactions, and rash. Severe allergic reactions and changes in blood counts may occur but are rare.
Traxium T 1.125
**Ceftriaxone 1g + Tazobactam 125mg Injection Description:**
Ceftriaxone 1g + Tazobactam 125mg injection is a broad-spectrum antibacterial medication used for the treatment of various bacterial infections. This combination therapy includes Ceftriaxone, a third-generation cephalosporin antibiotic that effectively targets a wide range of Gram-positive and Gram-negative bacteria, and Tazobactam, a beta-lactamase inhibitor that enhances the efficacy of Ceftriaxone by preventing the breakdown of the antibiotic by resistant bacteria.
**Indications:**
This injection is indicated for the treatment of moderate to severe infections, including:
- Pneumonia
- Urinary tract infections
- Skin and soft tissue infections
- Intra-abdominal infections
- Meningitis
**Dosage and Administration:**
The dosage and duration of therapy depend on the type and severity of the infection, as well as patient factors. It is typically administered intravenously or intramuscularly under the supervision of a healthcare professional.
**Contraindications:**
Ceftriaxone + Tazobactam injection should not be used in patients with a known allergy to cephalosporins, penicillins, or any component of the formulation. Caution is advised in patients with renal impairment or those receiving other nephrotoxic agents.
**Side Effects:**
Common side effects may include:
- Diarrhea
- Nausea
- Rash
- Local injection site reactions
Serious adverse effects, though rare, may occur, such as anaphylaxis, Clostridium difficile-associated diarrhea, and changes in liver function tests.
**Storage:**
Store in a cool, dry place, protected from light. Reconstituted solutions should be used promptly or stored as directed.
This combination of Ceftriaxone and Tazobactam offers a powerful option for combating infections resistant to standard treatments, making it a valuable choice in both hospital and outpatient settings. Always consult a healthcare professional for specific medical advice regarding this medication.
Mr. Vineet Kumar Arora (Novique Life Sciences)
Plot No. 371, 2nd Floor, Industrial Area Phase 2, Panchkula, Haryana - 134113
Share us via
